-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Landos Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Landos Biopharma, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$9.3M, a 43.5% decline year-over-year.
- Landos Biopharma, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$25.5M, a 20.4% increase year-over-year.
- Landos Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$22.7M, a 44% increase from 2022.
- Landos Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$40.6M, a 4.5% decline from 2021.
- Landos Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$38.8M, a 26.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)